Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Capital Expenditures (2016 - 2017)

Historic Capital Expenditures for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to $1.0.

  • Tenax Therapeutics' Capital Expenditures changed N/A to $1.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $4537.0, marking a year-over-year increase of 5731.62%. This contributed to the annual value of $5252.0 for FY2021, which is 5048.71% up from last year.
  • As of Q4 2017, Tenax Therapeutics' Capital Expenditures stood at $1.0.
  • In the past 5 years, Tenax Therapeutics' Capital Expenditures ranged from a high of $1.8 million in Q1 2014 and a low of $1.0 during Q4 2017
  • For the 5-year period, Tenax Therapeutics' Capital Expenditures averaged around $715164.8, with its median value being $10461.0 (2015).
  • As far as peak fluctuations go, Tenax Therapeutics' Capital Expenditures crashed by 9976.33% in 2015, and later soared by 1345.35% in 2017.
  • Quarter analysis of 5 years shows Tenax Therapeutics' Capital Expenditures stood at $1.8 million in 2013, then grew by 0.55% to $1.8 million in 2014, then plummeted by 99.07% to $16688.0 in 2015, then plummeted by 82.72% to $2884.0 in 2016, then plummeted by 99.97% to $1.0 in 2017.
  • Its Capital Expenditures stands at $1.0 for Q4 2017, versus $1264.0 for Q3 2017 and $3272.0 for Q1 2017.